Sangeeta Ghangam Manepalli is a Platform Architect in the Intel Client Computing Group (CCG), where she leads user experience-driven solution innovation for the Athena usages in client platforms.

In June 2020 PNC made a $1B commitment to help challenge systemic racism. We’ve made significant progress in carrying out that commitment. As of November 30, the Community Development Banking team has issued $339M in loans and investments.

For the second year in a row, NortonLifeLock celebrated Giving Tuesday by offering a special 2:1 Donation Match for all team members on November 30. Together we contributed at least $250,000 to incredible causes in just one day.

The financing provided for over 6,000 units of new & preserved housing for low- & moderate-income people. In addition, over 6 loans & investments went to development projects that will provide jobs & services for communities in the Bank’s footprint.

Yum! travels to East Asia where Tavan Bogd Group Executive Vice President Hulan Dashdavaa shares how she overcame adversity and grew her collection of businesses to include nearly 30 KFC and Pizza Hut restaurants in her home country. Here is her story.

Alibaba Group Holding Limited announced a pledge to achieve carbon neutrality in its own operations by 2030 and introduced a Scope 3+ target, a pioneering initiative aiming to facilitate 1.5 gigatons of decarbonization across its business by 2035.

“My child has a reason to smile. We used cans before, but now we have a reason to smile.” This is one of many heartfelt testimonials for the Utulav toilet, created by Syna Consultancy in Kenya.

Merck and Ridgeback Biotherapeutics announced the New England Journal of Medicine has published findings from the Phase 3 MOVe-OUT trial evaluating molnupiravir, an investigational oral antiviral COVID-19 medicine.

Principal Financial Group® reported today that small and medium-sized businesses1 (SMBs) are showing stronger current financial health and an increase in hiring, despite the ongoing impacts of COVID-19. At the same time, a shifting environment, lingering economic impacts from th

Illumina, Inc. (NASDAQ:ILMN), announced that it is supporting a national precision medicine study in Norway to assess the efficacy of blood-based comprehensive genomic profiling (CGP) in cancer therapy selection testing.